Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-30

Clinical Trial Update: Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating sodium bicarbonate supplementation in chronic kidney disease for dose-response, safety, and beneficial effects has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Chronic Kidney Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-08-30